What is the address of MOVIDA-MED?

The registered office of MOVIDA-MED is located at Jan Frans Gellyncklaan 170, 2540 Hove.

Is MOVIDA-MED still active?

Yes. According to the CBE (29 September 2026) MOVIDA-MED is active, legal situation “Normale toestand”, started on 2 March 2006.

Is MOVIDA-MED registered on Peppol?

Yes, MOVIDA-MED is registered on the Peppol network with ID 0208:0879709430.

What is the enterprise number of MOVIDA-MED?

The enterprise number of MOVIDA-MED is BE0879709430.

When was MOVIDA-MED founded?

MOVIDA-MED was founded on 2 March 2006.

Who are the directors of MOVIDA-MED?

According to the 2025 annual accounts, the directors of MOVIDA-MED are: Giovanni Prencipe.

Is MOVIDA-MED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 March 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MOVIDA-MED make in 2025?

MOVIDA-MED recorded a loss after taxes of € 165,375 in financial year 2025.

What is the revenue of MOVIDA-MED?

As a small company, MOVIDA-MED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 6,314.

MOVIDA-MED (Private Limited) - Hove - BE0879709430

Q: What does MOVIDA-MED do?

MOVIDA-MED is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 2 March 2006, 1 establishment.

Dossier MOVIDA-MED, printed on 29 September 2026 from databakkes.be/en/0879709430/movida-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

MOVIDA-MED from Hove, company number BE0879709430, closed financial year 2025 with a result of € -165,375 after tax. For that financial year MOVIDA-MED recorded a gross margin of € 6,314 and equity of € 66,243. Compared with financial year 2024, the result moved from € -12,612 to € -165,375. The company made a loss. The buffer shrank hard: equity is 71 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Shrank hard

€ 66,243

▼ 71% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -165,375

▼ 1211 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 58,854

▲ 9% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 29,093.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 18,600

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 16,404

€ 5,452 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 1,047

▼ 15% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,616

▲ € 5,548 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -11,385 Gross margin 2022: € -11,385 First fiscal year in the series	€ -14,181 Gross margin 2023: € -14,181 ▼ € 2,796 vs 2022 (€ -11,385) Unfavourable step	€ -11,036 Gross margin 2024: € -11,036 ▲ € 3,145 vs 2023 (€ -14,181) Favourable step	€ 6,314 Gross margin 2025: € 6,314 ▲ € 17,350 vs 2024 (€ -11,036) Favourable step	▲ € 17,350
Profit after taxes	€ -21,512 Profit after taxes 2022: € -21,512 First fiscal year in the series	€ -16,088 Profit after taxes 2023: € -16,088 ▲ € 5,425 vs 2022 (€ -21,512) Favourable step	€ -12,612 Profit after taxes 2024: € -12,612 ▲ € 3,476 vs 2023 (€ -16,088) Favourable step	€ -165,375 Profit after taxes 2025: € -165,375 ▼ € 152,764 vs 2024 (€ -12,612) Unfavourable step	▼ € 152,764
Equity	€ 260,317 Equity 2022: € 260,317 First fiscal year in the series	€ 244,229 Equity 2023: € 244,229 ▼ 6% vs 2022 (€ 260,317) Unfavourable step	€ 231,618 Equity 2024: € 231,618 ▼ 5% vs 2023 (€ 244,229) Unfavourable step	€ 66,243 Equity 2025: € 66,243 ▼ 71% vs 2024 (€ 231,618) Unfavourable step	▼ 71%
Total debts	€ 21,869 Total debts 2022: € 21,869 First fiscal year in the series	€ 18,445 Total debts 2023: € 18,445 ▼ 16% vs 2022 (€ 21,869) Favourable step	€ 7,842 Total debts 2024: € 7,842 ▼ 57% vs 2023 (€ 18,445) Favourable step	€ 24,068 Total debts 2025: € 24,068 ▲ 207% vs 2024 (€ 7,842) Unfavourable step	▲ 207%
Cash	€ 28,507 Cash 2022: € 28,507 First fiscal year in the series	€ 88,114 Cash 2023: € 88,114 ▲ 209% vs 2022 (€ 28,507) Favourable step	€ 54,213 Cash 2024: € 54,213 ▼ 38% vs 2023 (€ 88,114) Unfavourable step	€ 58,854 Cash 2025: € 58,854 ▲ 9% vs 2024 (€ 54,213) Favourable step	▲ 9%
Land & buildings	€ 84,390 Land & buildings 2022: € 84,390 First fiscal year in the series	€ 0 Land & buildings 2023: € 0 ▼ 100% vs 2022 (€ 84,390) Unchanged	-	-
Retained profit	€ 241,767 Retained profit 2022: € 241,767 First fiscal year in the series	€ 207,079 Retained profit 2023: € 207,079 ▼ 14% vs 2022 (€ 241,767) Unfavourable step	€ 194,468 Retained profit 2024: € 194,468 ▼ 6% vs 2023 (€ 207,079) Unfavourable step	€ 29,093 Retained profit 2025: € 29,093 ▼ 85% vs 2024 (€ 194,468) Unfavourable step	▼ 85%
Dividend	€ 16,335 Dividend 2022: € 16,335 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 16,335) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 16,404 Bank debt 2025: € 16,404 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 282,186 Balance sheet total 2022: € 282,186 First fiscal year in the series	€ 262,674 Balance sheet total 2023: € 262,674 ▼ 7% vs 2022 (€ 282,186) Unchanged	€ 239,460 Balance sheet total 2024: € 239,460 ▼ 9% vs 2023 (€ 262,674) Unchanged	€ 90,310 Balance sheet total 2025: € 90,310 ▼ 62% vs 2024 (€ 239,460) Unchanged	▼ 62%

Key figures of MOVIDA-MED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MOVIDA-MED?

What happened at MOVIDA-MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: loss of € 165,375. Source: NBB ↗
Mar 2, 2006 New establishment in Hove. KBO
Mar 2, 2006 Start of the company according to the CBE. KBO
2006 Giovanni Prencipe became a director. NBB

In short

From € 21,513 loss in 2022 to € 165,375 loss in 2025.

Paid € 1,385 in corporate taxes since 2022.

Paid out € 16,335 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at MOVIDA-MED? We notify you, reason included.

Follow MOVIDA-MED

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Giovanni Prencipe

MOVIDA-MED

Behind MOVIDA-MED is Giovanni Prencipe.

See the full network in the app

Directors

According to the 2025 annual accounts

Giovanni Prencipe

Director

since 2006

Establishments

Establishment units

Physical locations of this company

Registered office

Jan Frans Gellyncklaan 170

2540 Hove

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0879.709.430

VAT number

BE 0879.709.430

Registered office

Jan Frans Gellyncklaan 170, 2540 Hove

Names & denominations

MOVIDA-MED

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

2 March 2006

Peppol

Active · Active since 25 Sept 2024

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

MOVIDA-MED

Warning lights

Financials

What happened to MOVIDA-MED?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions